AMAZE 8: A Research Study Investigating How Well the Medicine NNC0487-0111 Compared to Semaglutide Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
NCT07400107 · PHASE3 · ACTIVE NOT RECRUITING · Sponsor: Novo Nordisk A/S · Conditions: Obesity, Overweight, Diabetes Mellitus, Type
PR
By Priya Raman · Science Reporter
Nov 10 07:00 ETSource: ClinicalTrials.gov
From the source
Read at clinicaltrials.govAMAZE 8: A Research Study Investigating How Well the Medicine NNC0487-0111 Compared to Semaglutide Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight
NCT07400107 · PHASE3 · ACTIVE NOT RECRUITING · Sponsor: Novo Nordisk A/S · Conditions: Obesity, Overweight, Diabetes Mellitus, Type 2.
Source URL https://clinicaltrials.gov/study/NCT07400107
